PCM
EW icon

Parsons Capital Management’s Edwards Lifesciences EW Stock Holding History

Parsons Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$250K Sell
3,120
-49
-2% -$4.04K 0.01% 443
2025
Q4 		$270K Hold
3,169
– – 0.01% 415
2025
Q3 		$246K Hold
3,169
– – 0.01% 421
2025
Q2 		$248K Hold
3,169
– – 0.02% 404
2025
Q1 		$230K Sell
3,169
-114
-3% -$8.16K 0.01% 406
2024
Q4 		$243K Sell
3,283
-486
-13% -$34K 0.01% 409
2024
Q3 		$249K Hold
3,769
– – 0.02% 403
2024
Q2 		$348K Sell
3,769
-67
-2% -$5.93K 0.02% 353
2024
Q1 		$367K Sell
3,836
-9
-0.2% -$756 0.03% 353
2023
Q4 		$293K Buy
3,845
+12
+0.3% +$835 0.02% 378
2023
Q3 		$266K Buy
3,833
+8
+0.2% +$643 0.02% 375
2023
Q2 		$361K Sell
3,825
-8
-0.2% -$695 0.03% 344
2023
Q1 		$317K Sell
3,833
-115
-3% -$9.04K 0.03% 354
2022
Q4 		$295K Buy
3,948
+16
+0.4% +$1.23K 0.02% 359
2022
Q3 		$325K Buy
3,932
+23
+0.6% +$2.21K 0.03% 336
2022
Q2 		$372K Buy
3,909
+52
+1% +$5.38K 0.03% 324
2022
Q1 		$454K Buy
3,857
+89
+2% +$9.98K 0.03% 318
2021
Q4 		$488K Sell
3,768
-1
-0% -$117 0.04% 315
2021
Q3 		$427K Sell
3,769
-8
-0.2% -$913 0.03% 315
2021
Q2 		$391K Buy
3,777
+2
+0.1% +$189 0.03% 322
2021
Q1 		$316K Buy
3,775
+3
+0.1% +$254 0.03% 338
2020
Q4 		$344K Buy
3,772
+1
+0% +$83 0.03% 302
2020
Q3 		$301K Buy
3,771
+3
+0.1% +$234 0.03% 296
2020
Q2 		$260K Hold
3,768
– – 0.03% 305
2020
Q1 		$237K Sell
3,768
-735
-16% -$53K 0.03% 283
2019
Q4 		$350K Buy
4,503
+597
+15% +$46.6K 0.04% 279
2019
Q3 		$286K Sell
3,906
-234
-6% -$16.4K 0.03% 293
2019
Q2 		$255K Sell
4,140
-3
-0.1% -$181 0.03% 306
2019
Q1 		$264K Buy
+4,143
New +$236K 0.03% 301

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Parsons Capital Management's EW Position: Q1 2026 in Review

Parsons Capital Management reduced its Edwards Lifesciences (EW) stake by 1.5% in Q1 2026, selling an estimated $4.04K and leaving 3,120 shares worth $250K. The position accounts for 0.01% of the portfolio, ranked #443.

Parsons Capital Management first reported a position in EW in Q1 2019 and has held it in 29 quarters since. The position peaked at $488K in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Parsons Capital Management held 3,120 shares of Edwards Lifesciences worth $250K as of Q1 2026.
  • Parsons Capital Management sold 49 Edwards Lifesciences shares in Q1 2026, an estimated $4.04K.
  • Edwards Lifesciences made up 0.01% of Parsons Capital Management's portfolio in Q1 2026, its #443 holding.
  • Parsons Capital Management first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 29 quarters since.
  • Parsons Capital Management's Edwards Lifesciences position peaked at $488K in Q4 2021.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Parsons Capital Management's 13F filing for Q1 2026, filed 15 Apr 2026.